Abbott Laboratories

NYSE: ABT
$105.27
-$0.63 (-0.6%)
Closing price April 18, 2024
Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices. Founded in 1888 and headquartered in North Chicago, Illinois, Abbott is known for its innovative solutions in managing health conditions such as diabetes, cardiovascular diseases, and chronic pain. It also offers a range of diagnostics equipment and tests for infectious diseases, including HIV and influenza, as well as nutritional products for both pediatric and adult patients. Abbott's commitment to improving lives is evident through its diverse offerings aimed at enhancing health and well-being worldwide.
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession. With even moderate appreciation in their share prices, investors should...
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Before U.S. markets open on Wednesday, these four companies are set to report quarterly earnings.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic...
U.S. equities are trading somewhat higher in Tuesday's premarket session as investors wait to hear what Federal Reserve chief Jerome Powell has to say to Congress.
With the potential for big downside still looming, and interest rates definitely headed higher, stock investors may want to consider these seven Dividend Aristocrats that posted solid third-quarter...
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Biohaven, Edwards Lifesciences, Enphase Energy, Halliburton, Invesco, Liberty Energy, Mattel, Netflix, Permian Resources,...
Here is a look at what to expect from these four companies when they report quarterly results before markets open on Wednesday.
With the potential for a serious downside move looming, and interest rates definitely headed higher, investors may want to consider the Dividend Aristocrats. These seven are in defensive sectors and...
After markets close Tuesday, video streaming giant Netflix will report quarterly earnings that are not expected to be a significant improvement over prior quarter results. Four other firms report...
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Azul, Boeing, Boston Scientific, Callon Petroleum, Corning, Datadog, Etsy, HCA Healthcare, Kohl's, Medtronic, Merck,...
In a market that is very volatile, and that could be headed much lower if we are already in a recession, these seven safe-haven stocks make a ton of sense now. With even moderate appreciation in the...
Here is what to expect when three leading companies in different sectors report quarterly results before markets open on Wednesday.